-
Je něco špatně v tomto záznamu ?
Long-term visual damage after acute methanol poisonings: Longitudinal cross-sectional study in 50 patients
S. Zakharov, D. Pelclova, P. Diblik, P. Urban, P. Kuthan, O. Nurieva, K. Kotikova, T. Navratil, M. Komarc, J. Belacek, Z. Seidl, M. Vaneckova, JA. Hubacek, O. Bezdicek, J. Klempir, M. Yurchenko, E. Ruzicka, M. Miovsky, B. Janikova, KE. Hovda,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- akutní nemoc MeSH
- bazální ganglia účinky léků patofyziologie MeSH
- časové faktory MeSH
- diagnostické techniky oftalmologické MeSH
- dospělí MeSH
- epidemický výskyt choroby * MeSH
- hodnocení rizik MeSH
- lidé středního věku MeSH
- lidé MeSH
- lineární modely MeSH
- logistické modely MeSH
- longitudinální studie MeSH
- methanol otrava MeSH
- mladý dospělý MeSH
- multivariační analýza MeSH
- nervus opticus účinky léků patofyziologie MeSH
- obnova funkce MeSH
- ochranné faktory MeSH
- odds ratio MeSH
- otrava diagnóza epidemiologie patofyziologie terapie MeSH
- poruchy zraku chemicky indukované diagnóza epidemiologie patofyziologie terapie MeSH
- prediktivní hodnota testů MeSH
- prevalence MeSH
- průřezové studie MeSH
- retina účinky léků patofyziologie MeSH
- rizikové faktory MeSH
- rozdělení chí kvadrát MeSH
- senioři MeSH
- výsledek terapie MeSH
- zrak účinky léků MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladý dospělý MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Geografické názvy
- Česká republika MeSH
CONTEXT: Visual disturbances due to the toxic effect of formic acid in acute methanol poisonings are generally transient. The subjective symptoms of visual toxicity may resolve within few weeks and fundoscopic signs of acute optic neuropathy subside within 1-2 months; therefore, the prevalence of long-term visual sequelae in the population of survivors of poisonings may be underestimated. OBJECTIVE: To study the prevalence and character of long-term visual sequelae of acute methanol poisonings based on the data from the Czech mass methanol outbreak in 2012. PATIENTS AND METHODS: A total of 50 patients with confirmed methanol poisoning were included in this longitudinal cross-sectional study, median age: 48 (range, 23-73) years. The following tests were performed: optical coherence tomography or OCT with evaluation of the retinal nerve fibers layer (RNFL), visual evoked potentials (VEP), magnetic resonance imaging (MRI) of brain, complete ocular examination (visual acuity/field, color vision, contrast sensitivity, and fundus), neurological examinations, and biochemical tests. RESULTS: Of 50 patients, 7/50 (14%) were discharged with diagnosed visual sequelae and 6/50 (12%) were discharged with both visual and central nervous system sequelae of poisoning. On the follow-up examination, 20/50 (40%) of the patients had long-term visual sequelae, with 8% of blindness. A total of 38% of the patients had abnormal (28% borderline) findings on RNFL, and 40% had abnormal (18% borderline) VEP. Among the patients discharged without detected visual sequelae, 8/37 (22%) had abnormal RNFL and VEP. Patients with visual sequelae had brain lesions more often (70% vs. 27%, p < 0.01). MRI identified optic nerve lesions in 2/20 cases with abnormal VEP only. The groups with and without visual sequelae differed in serum methanol, ethanol, HCO3-, formate, pH, anion gap, and base deficit (all p < 0.01). Visual disturbances on admission and coma were more prevalent in the patients with visual sequelae (p < 0.05). Patients with positive serum ethanol on admission were 93% less likely to have optical axonal damage (OR: 0.07 (95% CI: 0.01-0.8); p < 0.05). No association was found between visual sequelae and type of antidote administered, mode of hemodialysis, or folate substitution. Pre-hospital administration of ethanol seemed beneficial: these patients were 90% less likely to have abnormal RNFL findings (OR: 0.10 (95% CI: 0.02-0.52); p < 0.01). CONCLUSIONS: The long-term visual sequelae were clearly underestimated on discharge, suggesting a significantly higher amount of patients with long-term sequelae than earlier reported. Thorough examinations before discharge and during follow-up will likely uncover a higher morbidity also after methanol poisonings in general.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc16009964
- 003
- CZ-PrNML
- 005
- 20160413094945.0
- 007
- ta
- 008
- 160408s2015 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3109/15563650.2015.1086488 $2 doi
- 024 7_
- $a 10.3109/15563650.2015.1086488 $2 doi
- 035 __
- $a (PubMed)26364866
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Zakharov, Sergey $u a Toxicological Information Center, Department of Occupational Medicine , First Faculty of Medicine, Charles University in Prague and General University Hospital , Prague 2, Czech Republic.
- 245 10
- $a Long-term visual damage after acute methanol poisonings: Longitudinal cross-sectional study in 50 patients / $c S. Zakharov, D. Pelclova, P. Diblik, P. Urban, P. Kuthan, O. Nurieva, K. Kotikova, T. Navratil, M. Komarc, J. Belacek, Z. Seidl, M. Vaneckova, JA. Hubacek, O. Bezdicek, J. Klempir, M. Yurchenko, E. Ruzicka, M. Miovsky, B. Janikova, KE. Hovda,
- 520 9_
- $a CONTEXT: Visual disturbances due to the toxic effect of formic acid in acute methanol poisonings are generally transient. The subjective symptoms of visual toxicity may resolve within few weeks and fundoscopic signs of acute optic neuropathy subside within 1-2 months; therefore, the prevalence of long-term visual sequelae in the population of survivors of poisonings may be underestimated. OBJECTIVE: To study the prevalence and character of long-term visual sequelae of acute methanol poisonings based on the data from the Czech mass methanol outbreak in 2012. PATIENTS AND METHODS: A total of 50 patients with confirmed methanol poisoning were included in this longitudinal cross-sectional study, median age: 48 (range, 23-73) years. The following tests were performed: optical coherence tomography or OCT with evaluation of the retinal nerve fibers layer (RNFL), visual evoked potentials (VEP), magnetic resonance imaging (MRI) of brain, complete ocular examination (visual acuity/field, color vision, contrast sensitivity, and fundus), neurological examinations, and biochemical tests. RESULTS: Of 50 patients, 7/50 (14%) were discharged with diagnosed visual sequelae and 6/50 (12%) were discharged with both visual and central nervous system sequelae of poisoning. On the follow-up examination, 20/50 (40%) of the patients had long-term visual sequelae, with 8% of blindness. A total of 38% of the patients had abnormal (28% borderline) findings on RNFL, and 40% had abnormal (18% borderline) VEP. Among the patients discharged without detected visual sequelae, 8/37 (22%) had abnormal RNFL and VEP. Patients with visual sequelae had brain lesions more often (70% vs. 27%, p < 0.01). MRI identified optic nerve lesions in 2/20 cases with abnormal VEP only. The groups with and without visual sequelae differed in serum methanol, ethanol, HCO3-, formate, pH, anion gap, and base deficit (all p < 0.01). Visual disturbances on admission and coma were more prevalent in the patients with visual sequelae (p < 0.05). Patients with positive serum ethanol on admission were 93% less likely to have optical axonal damage (OR: 0.07 (95% CI: 0.01-0.8); p < 0.05). No association was found between visual sequelae and type of antidote administered, mode of hemodialysis, or folate substitution. Pre-hospital administration of ethanol seemed beneficial: these patients were 90% less likely to have abnormal RNFL findings (OR: 0.10 (95% CI: 0.02-0.52); p < 0.01). CONCLUSIONS: The long-term visual sequelae were clearly underestimated on discharge, suggesting a significantly higher amount of patients with long-term sequelae than earlier reported. Thorough examinations before discharge and during follow-up will likely uncover a higher morbidity also after methanol poisonings in general.
- 650 _2
- $a akutní nemoc $7 D000208
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a bazální ganglia $x účinky léků $x patofyziologie $7 D001479
- 650 _2
- $a rozdělení chí kvadrát $7 D016009
- 650 _2
- $a průřezové studie $7 D003430
- 650 _2
- $a diagnostické techniky oftalmologické $7 D003941
- 650 12
- $a epidemický výskyt choroby $7 D004196
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a lineární modely $7 D016014
- 650 _2
- $a logistické modely $7 D016015
- 650 _2
- $a longitudinální studie $7 D008137
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a methanol $x otrava $7 D000432
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a multivariační analýza $7 D015999
- 650 _2
- $a odds ratio $7 D016017
- 650 _2
- $a nervus opticus $x účinky léků $x patofyziologie $7 D009900
- 650 _2
- $a otrava $x diagnóza $x epidemiologie $x patofyziologie $x terapie $7 D011041
- 650 _2
- $a prediktivní hodnota testů $7 D011237
- 650 _2
- $a prevalence $7 D015995
- 650 _2
- $a ochranné faktory $7 D065840
- 650 _2
- $a obnova funkce $7 D020127
- 650 _2
- $a retina $x účinky léků $x patofyziologie $7 D012160
- 650 _2
- $a hodnocení rizik $7 D018570
- 650 _2
- $a rizikové faktory $7 D012307
- 650 _2
- $a časové faktory $7 D013997
- 650 _2
- $a výsledek terapie $7 D016896
- 650 _2
- $a poruchy zraku $x chemicky indukované $x diagnóza $x epidemiologie $x patofyziologie $x terapie $7 D014786
- 650 _2
- $a zrak $x účinky léků $7 D014785
- 650 _2
- $a mladý dospělý $7 D055815
- 651 _2
- $a Česká republika $x epidemiologie $7 D018153
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Pelclova, Daniela $u a Toxicological Information Center, Department of Occupational Medicine , First Faculty of Medicine, Charles University in Prague and General University Hospital , Prague 2, Czech Republic.
- 700 1_
- $a Diblik, Pavel $u b Department of Ophthalmology , First Faculty of Medicine, Charles University in Prague and General University Hospital , Prague 2, Czech Republic.
- 700 1_
- $a Urban, Pavel $u a Toxicological Information Center, Department of Occupational Medicine , First Faculty of Medicine, Charles University in Prague and General University Hospital , Prague 2, Czech Republic.
- 700 1_
- $a Kuthan, Pavel $u b Department of Ophthalmology , First Faculty of Medicine, Charles University in Prague and General University Hospital , Prague 2, Czech Republic.
- 700 1_
- $a Nurieva, Olga $u a Toxicological Information Center, Department of Occupational Medicine , First Faculty of Medicine, Charles University in Prague and General University Hospital , Prague 2, Czech Republic.
- 700 1_
- $a Kotikova, Katerina $u a Toxicological Information Center, Department of Occupational Medicine , First Faculty of Medicine, Charles University in Prague and General University Hospital , Prague 2, Czech Republic.
- 700 1_
- $a Navratil, Tomas $u c Department of Biomimetic Electrochemistry , J. Heyrovský Institute of Physical Chemistry of the AS CR , v.v.i, Prague 8 , Czech Republic. d Institute of Medical Biochemistry and Laboratory Medicine, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague , Prague 2, Czech Republic.
- 700 1_
- $a Komarc, Martin $u e Institute of Biophysics and Informatics, First Faculty of Medicine of Charles University in Prague, General University Hospital , Prague 2, Czech Republic.
- 700 1_
- $a Belacek, Jaromir $u e Institute of Biophysics and Informatics, First Faculty of Medicine of Charles University in Prague, General University Hospital , Prague 2, Czech Republic.
- 700 1_
- $a Seidl, Zdenek $u f Department of Radiology , First Faculty of Medicine, Charles University in Prague and General University Hospital , Prague 2, Czech Republic.
- 700 1_
- $a Vaneckova, Manuela $u f Department of Radiology , First Faculty of Medicine, Charles University in Prague and General University Hospital , Prague 2, Czech Republic.
- 700 1_
- $a Hubacek, Jaroslav A $u g Centre for Experimental Medicine, Institute for Clinical and Experimental medicine , Prague 4 , Czech Republic.
- 700 1_
- $a Bezdicek, Ondrej $u h Department of Neurology and Center of Clinical Neuroscience , First Faculty of Medicine, Charles University in Prague and General University Hospital , Prague 2, Czech Republic.
- 700 1_
- $a Klempir, Jiri $u h Department of Neurology and Center of Clinical Neuroscience , First Faculty of Medicine, Charles University in Prague and General University Hospital , Prague 2, Czech Republic.
- 700 1_
- $a Yurchenko, Maksim $u i Institute of Clinical and Experimental Dental Medicine, First Faculty of Medicine, Charles University in Prague and General University Hospital , Prague 2, Czech Republic.
- 700 1_
- $a Ruzicka, Evzen $u h Department of Neurology and Center of Clinical Neuroscience , First Faculty of Medicine, Charles University in Prague and General University Hospital , Prague 2, Czech Republic.
- 700 1_
- $a Miovsky, Michal $u j Department of Addictology , First Faculty of Medicine, Charles University in Prague and General University Hospital , Prague 2, Czech Republic.
- 700 1_
- $a Janikova, Barbara $u j Department of Addictology , First Faculty of Medicine, Charles University in Prague and General University Hospital , Prague 2, Czech Republic.
- 700 1_
- $a Hovda, Knut Erik $u k The Norwegian CBRNe Centre of Medicine, Department of Acute Medicine , Oslo University Hospital , Oslo , Norway.
- 773 0_
- $w MED00013938 $t Clinical toxicology (Philadelphia, Pa.) $x 1556-9519 $g Roč. 53, č. 9 (2015), s. 884-92
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/26364866 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20160408 $b ABA008
- 991 __
- $a 20160413095029 $b ABA008
- 999 __
- $a ok $b bmc $g 1113393 $s 934332
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 53 $c 9 $d 884-92 $e 20150912 $i 1556-9519 $m Clinical toxicology $n Clin Toxicol (Phila) $x MED00013938
- LZP __
- $a Pubmed-20160408